These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11469385)

  • 1. Biopharmaceutical powders: particle formation and formulation considerations.
    Maa YF; Prestrelski SJ
    Curr Pharm Biotechnol; 2000 Nov; 1(3):283-302. PubMed ID: 11469385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
    Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of Inhalable Dry Powder Formulations Loaded with Nanoparticles Maintaining Their Original Physical Properties and Functions].
    Okuda T
    Yakugaku Zasshi; 2017; 137(11):1339-1348. PubMed ID: 29093369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein inhalation powders: spray drying vs spray freeze drying.
    Maa YF; Nguyen PA; Sweeney T; Shire SJ; Hsu CC
    Pharm Res; 1999 Feb; 16(2):249-54. PubMed ID: 10100310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spray-coating for biopharmaceutical powder formulations: beyond the conventional scale and its application.
    Maa YF; Ameri M; Rigney R; Payne LG; Chen D
    Pharm Res; 2004 Mar; 21(3):515-23. PubMed ID: 15070104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of proteins in dry powder formulations using supercritical fluid technology.
    Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
    Pharm Res; 2004 Nov; 21(11):1955-69. PubMed ID: 15587916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability Comparison Between Microglassification and Lyophilization Using a Monoclonal Antibody.
    Chandrababu KB; Kannan A; Savage JR; Stadmiller S; Ryle AE; Cheung C; Kelley RF; Maa YF; Saggu M; Bitterfield DL
    J Pharm Sci; 2024 Apr; 113(4):1054-1060. PubMed ID: 37863428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Powder suspensions in non-aqueous vehicles for delivery of therapeutic proteins.
    Marschall C; Witt M; Hauptmeier B; Friess W
    Eur J Pharm Biopharm; 2021 Apr; 161():37-49. PubMed ID: 33548460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals.
    Emami F; Keihan Shokooh M; Mostafavi Yazdi SJ
    J Pharm Investig; 2023; 53(1):35-57. PubMed ID: 36568503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation.
    Saluja V; Amorij JP; Kapteyn JC; de Boer AH; Frijlink HW; Hinrichs WL
    J Control Release; 2010 Jun; 144(2):127-33. PubMed ID: 20219608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation.
    van Drooge DJ; Hinrichs WL; Dickhoff BH; Elli MN; Visser MR; Zijlstra GS; Frijlink HW
    Eur J Pharm Sci; 2005 Oct; 26(2):231-40. PubMed ID: 16084699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
    Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
    J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spray granulation for drug formulation.
    Loh ZH; Er DZ; Chan LW; Liew CV; Heng PW
    Expert Opin Drug Deliv; 2011 Dec; 8(12):1645-61. PubMed ID: 22097906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Protein-Excipient Microheterogeneity in Biopharmaceutical Solid-State Formulations by Confocal Fluorescence Microscopy.
    Koshari SH; Ross JL; Nayak PK; Zarraga IE; Rajagopal K; Wagner NJ; Lenhoff AM
    Mol Pharm; 2017 Feb; 14(2):546-553. PubMed ID: 28094996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
    Grohganz H; Lee YY; Rantanen J; Yang M
    Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation.
    Maa YF; Ameri M; Shu C; Payne LG; Chen D
    J Pharm Sci; 2004 Jul; 93(7):1912-23. PubMed ID: 15176078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation Screening and Freeze-Drying Process Optimization of Ginkgolide B Lyophilized Powder for Injection.
    Liu D; Galvanin F; Yu Y
    AAPS PharmSciTech; 2018 Feb; 19(2):541-550. PubMed ID: 28849380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid Recovery of Clofazimine-Loaded Nanoparticles with Long-Term Storage Stability as Anti-
    Feng J; Zhang Y; McManus SA; Ristroph KD; Lu HD; Gong K; White CE; Prud'homme RK
    ACS Appl Nano Mater; 2018 May; 1(5):2184-2194. PubMed ID: 29911689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying.
    Saboti D; Maver U; Chan HK; Planinšek O
    J Pharm Sci; 2017 Jul; 106(7):1881-1888. PubMed ID: 28285981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dry Powder Formulation of Plasmid DNA and siRNA for Inhalation.
    Chow MY; Lam JK
    Curr Pharm Des; 2015; 21(27):3854-66. PubMed ID: 26290202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.